The BCMM is leading two collaborative initiatives around our primary areas of focus: early life microbiome development and microbiome interactions with disease therapeutics.
PREMO: Premature Microbiome and Outcomes
In partnership with the UCSF PROMPT study and the California Preterm Birth Initiative (PTBi-CA), PREMO aims to develop a greater understanding of the role of the early-life microbiome in preterm infant development. Initial activities include development of a large, well-characterized and densely longitudinally sampled preterm infant birth cohort, building a resource for current and future integrative research efforts.
Learn more about PREMO Initiative.
Therapeutics
The BCMM is investigating how drugs, including microbe- and host-targeted small molecules and biologics, drive inter-individual variations in the microbiome structure and function with the aim of both repositioning existing drugs and developing novel microbial-derived bioactives for treatment of inflammatory disease.
